v3.25.1
Segment Information (Tables)
3 Months Ended
Mar. 29, 2025
Segment Reporting [Abstract]  
Schedule of Segment Information
The following tables present the Company's segment information for the 13 weeks ended March 29, 2025 and March 30, 2024 (in $000's):
Thirteen Weeks Ended
March 29, 2025March 30, 2024
Revenues
Fintech$5,514 $— 
Biotech— — 
Corporate and other— — 
Total Revenues$5,514 $— 
Gross profit
Fintech$2,591 $— 
Biotech— — 
Corporate and other— — 
Total Gross profit$2,591 $— 
Operating loss
Fintech$(362)$— 
Biotech(540)(701)
Corporate and other(1,268)(1,105)
Total Operating loss$(2,170)$(1,806)
Depreciation and amortization
Fintech$728 $— 
Biotech482 639 
Corporate and other— — 
Total Depreciation and amortization$1,210 $639 
Interest expense, net
Fintech$376 $— 
Biotech— 252 
Corporate and other344 — 
Total Interest expense, net$720 $252 
Net loss before income taxes
Fintech$(346)$— 
Biotech(540)(701)
Corporate and other(1,690)(1,518)
Total Net income before income taxes$(2,576)$(2,219)